Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Kromek Group plc ( (GB:KMK) ) just unveiled an announcement.
Kromek Group plc announced its upcoming Annual General Meeting and the publication of its annual report, alongside significant changes in its board of directors. Long-serving Non-executive Directors Lawrence Kinet and Jerel Whittingham will retire, and Matt Boyle will join as a Non-executive Director and Chair of the Remuneration Committee. Boyle brings extensive experience in engineering and business, having transformed Sevcon Inc into a high-growth electrification company. His appointment is expected to aid Kromek in achieving sustainable, profitable growth.
The most recent analyst rating on (GB:KMK) stock is a Hold with a £6.00 price target. To see the full list of analyst forecasts on Kromek Group plc stock, see the GB:KMK Stock Forecast page.
Spark’s Take on GB:KMK Stock
According to Spark, TipRanks’ AI Analyst, GB:KMK is a Neutral.
The overall score of 56 reflects a stock with moderate strengths and notable challenges. Positive corporate events and technical indicators provide optimism, but ongoing financial and profitability issues weigh heavily on the score.
To see Spark’s full report on GB:KMK stock, click here.
More about Kromek Group plc
Kromek Group plc is a leading developer of radiation detection and bio-detection technology solutions, focusing on advanced imaging and CBRN detection markets. Headquartered in County Durham, UK, the company operates manufacturing facilities in the UK and US. Kromek’s products serve medical, security, industrial, and homeland defense markets, providing detector components for disease detection, industrial contamination, and nuclear radiation threats.
Average Trading Volume: 1,971,213
Technical Sentiment Signal: Buy
Current Market Cap: £40.94M
Learn more about KMK stock on TipRanks’ Stock Analysis page.